Intuitive Surgical, Inc. $ISRG Holdings Raised by Northwestern Mutual Wealth Management Co.

Key Points

• Northwestern Mutual Wealth Management increased its Intuitive Surgical stake by 9.6% in the fourth quarter, adding 11,294 shares to bring its total to 128,681 shares worth about $72.9 million.
• Institutional ownership remains heavy, with 83.64% of Intuitive Surgical’s stock held by institutions and hedge funds, even as several smaller investors also added positions.
• Analyst sentiment is still broadly positive: the stock has a “Moderate Buy” consensus, with 19 Buy ratings versus seven Hold and one Sell, and a current average price target of $576.71.

Northwestern Mutual Wealth Management Co. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 128,681 shares of the medical equipment provider's stock after acquiring an additional 11,294 shares during the period. Northwestern Mutual Wealth Management Co.'s holdings in Intuitive Surgical were worth $72,880,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in ISRG. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $25,000. Newbridge Financial Services Group Inc. boosted its position in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 33 shares during the period. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical during the third quarter valued at approximately $27,000. Olistico Wealth LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Caitlin John LLC bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the business's stock in a transaction on Monday, May 11th. The shares were sold at an average price of $446.95, for a total value of $178,780.00. Following the sale, the executive vice president owned 6,120 shares of the company's stock, valued at $2,735,334. The trade was a 6.13% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction on Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the transaction, the director owned 120 shares of the company's stock, valued at approximately $55,620. This represents a 49.79% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 5,481 shares of company stock valued at $2,673,871. Company insiders own 0.60% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Evercore decreased their price objective on shares of Intuitive Surgical from $550.00 to $480.00 and set a "neutral" rating for the company in a report on Monday, April 6th. Truist Financial lowered their price target on Intuitive Surgical from $650.00 to $580.00 and set a "buy" rating on the stock in a research report on Wednesday, April 15th. Robert W. Baird lifted their price objective on Intuitive Surgical from $575.00 to $610.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 22nd. Leerink Partners decreased their target price on Intuitive Surgical from $622.00 to $573.00 and set an "outperform" rating for the company in a research note on Wednesday, April 22nd. Finally, Piper Sandler dropped their price target on Intuitive Surgical from $620.00 to $580.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $576.71.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street optimism is supporting the stock, with one article arguing Intuitive Surgical could rise more than 30% from current levels because analysts believe the long-term growth story remains intact and the recent selloff has created an attractive entry point. Article Title
• Positive Sentiment: Intuitive Surgical announced a leadership change in commercial and marketing, promoting Taylor Patton to Chief Commercial and Marketing Officer effective July 1, which may be viewed as a continuity move that could support execution and sales strategy. Article Title
• Neutral Sentiment: Market commentary noted the stock is still trading well below its recent high, underscoring that investor caution remains elevated even though the company continues to be viewed as a leader in robotic-assisted surgery. Article Title
• Neutral Sentiment: Third-party market reports described ISRG as underperforming peers and highlighted recent short-interest data, but the figures did not show a clear new bearish catalyst. Article Title
• Neutral Sentiment: Intuitive Surgical also appeared in broader “physical AI” and robotics commentary, which is more of a thematic mention than a company-specific catalyst for the stock. Article Title

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $424.59 on Friday. The firm has a 50-day simple moving average of $453.54 and a 200 day simple moving average of $506.43. Intuitive Surgical, Inc. has a twelve month low of $414.30 and a twelve month high of $603.88. The stock has a market cap of $150.37 billion, a PE ratio of 51.47, a PEG ratio of 3.38 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company's quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.81 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.